Navigation Links
NPS Pharmaceuticals Names Brian O'Callaghan as New Chief Commercial Officer
Date:10/8/2007

BEDMINSTER, N.J., Oct. 8 /PRNewswire-FirstCall/ -- NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) announced today the appointment of Brian O'Callaghan as senior vice president and chief commercial officer, effective October 15, 2007.

As a member of the NPS executive team, Mr. O'Callaghan will be responsible for managing the company's marketing and corporate and business development activities, including the commercial development of NPS's late-stage products and coordination of its joint-venture partnerships with other companies. He will report to Dr. Francois Nader, executive vice president and chief operating officer of NPS.

Mr. O'Callaghan joins NPS from Covance, a global clinical research organization, where he served as general manager of the cardiac safety and IVRS business units. Previously he was North American regional business unit head for infectious diseases and transplantation/immunology at Novartis, president of BioPartners GmbH, and held sales and marketing positions at Merck KGaA, Merck & Lipha Pharmaceuticals and Pfizer.

"Brian brings to NPS more than 15 years of experience in pharmaceutical sales, marketing, business development and general management," said Dr. Nader. "We welcome his contributions to the commercialization of our late-stage product candidates PREOS(R) and GATTEX(TM) and to the success of our earlier-stage corporate collaborations."

Mr. O'Callaghan has a master's degree in business administration from Henley College and a marketing degree from Cork Regional College/Marketing Institute of Ireland.

About NPS

NPS Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of small molecules and recombinant proteins as drug
'/>"/>

SOURCE NPS Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Supply of Radiopharmaceuticals Hampered by Attacks
2. FDA approves Watson Pharmaceuticals Oxytrol patch
3. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
4. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
5. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
6. Top Pharmaceuticals Influence Doctors Prescriptions
7. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals
8. Personalized Medicine and Innovative Pharmaceuticals
9. New lease of life for asthmatics by Accentia Biopharmaceuticals
10. Pravastatin Launched by Watson Pharmaceuticals
11. Tata Industries picks up stake in Indigene Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... With Memorial Day Weekend upon us, cookout season has officially ... to help prevent grill fires throughout the spring and summer. ... that gas grills led to an average of 7,100 home ... meanwhile, caused approximately 1,200 home fires per year during that ... the following tips from the NFPA to help protect your ...
(Date:5/24/2013)... Calif.) (PRWEB) May 24, 2013 ... House Appropriators and the California congressional delegation, joined ... restore sequestered industry user fees paid to the ... to ensure that future across-the-board cuts will not ... of the FY14 Agriculture, Rural Development and FDA ...
(Date:5/24/2013)... 2013 Let’s face it: very few are ... for the majority of people to be uncomfortable with the ... a coffee addiction or simply genetics, yellowish or stained teeth ... popular. , Herald Square Dental is proud to ... system: Venus White Max. , Teeth become discolored for ...
(Date:5/24/2013)... The nation’s first trial of a ... da Vinci Surgical System concluded yesterday, Bernstein Liebhard LLP ... Court jury ruled in a 10-to-2 decision that Intuitive ... performed a da Vinci prostatectomy on a patient who ... alleged in their lawsuit that the da Vinci complications ...
(Date:5/24/2013)... May 24, 2013 BestSatelliteProviders.com the ... helped thousands of consumers compare the features and ... reviews site recently released the rankings of the ... are available for viewing on their website. ... , According to Adam Matthews, the spokesperson for ...
Breaking Medicine News(10 mins):Health News:Don’t Get Burned: Five Grilling Tips from Amica Insurance 2Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 2Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 3Health News:Herald Square Dental Introduces New In-office Whitening System: Venus White Max 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications 3Health News:Best Rural Internet Service Provider in 2013 by BestSatelliteProviders.com 2
... ... 2008 SpeechNutrients introduced the supplement NourishLife speak™ which combines omega-3 and ... speech challenges. A recent study published in the July issue ... with verbal apraxia taking a combination of omega-3 and vitamin E ...
... ... Dysport. Dysport is the first rival for Botox. Dr. Pilest met with Medicis CEO Jonah ... who were involved in FDA trials for Dysport. , ... Irvine, CA (PRWEB) August 13, 2009 -- Dr. Nissan Pilest was ...
... , FRANKLIN LAKES, N.J. and LONDON, ... ), the world,s most advanced pharmacy(R) , today extended its ... with United Drug plc, a Pan-European healthcare leader, to provide home-based ... the country,s National Health Service (NHS). The NHS provides healthcare ...
... SILVER SPRING, Md., Aug. 12 The Association ... million in first-year funding through the President,s Emergency Plan ... laboratories and laboratory systems in participating countries. The five-year ... Centers for Disease Control and Prevention (CDC) will support ...
... survivors who lift weights are less likely than their ... arm- and hand-swelling condition that plagues many women following ... Pennsylvania School of Medicine research published in the August ... Medicine . The findings challenge the advice commonly given ...
... , , CHICAGO, Aug. 12 ... comments President Obama continues to make about the high-quality care provided by ... incorrect or not based in fact, we think he does a disservice ... facts about health care reform. We want to set the record ...
Cached Medicine News:Health News:Newly Published Research Indicates 97% of Apraxic Children Improving with Novel Nutritional Combination 2Health News:Newly Published Research Indicates 97% of Apraxic Children Improving with Novel Nutritional Combination 3Health News:Newly Published Research Indicates 97% of Apraxic Children Improving with Novel Nutritional Combination 4Health News:Orange County Derm Nissan Pilest Selected to Become Physician Trainer for Dysport 2Health News:Orange County Derm Nissan Pilest Selected to Become Physician Trainer for Dysport 3Health News:Medco Health Solutions, United Drug Announce U.K. Homecare Pharmacy Joint Venture Serving Patients with Chronic and Complex Health Conditions; Innovations to Improve Clinical Quality, Reduce Costs 2Health News:Medco Health Solutions, United Drug Announce U.K. Homecare Pharmacy Joint Venture Serving Patients with Chronic and Complex Health Conditions; Innovations to Improve Clinical Quality, Reduce Costs 3Health News:APHL Chosen by PEPFAR to Develop Global Health Laboratory Systems 2Health News:Lifting weights reduces lymphedema symptoms following breast cancer surgery, Penn research shows 2Health News:Lifting weights reduces lymphedema symptoms following breast cancer surgery, Penn research shows 3Health News:Statement from the American College of Surgeons Regarding Recent Comments from President Obama 2
(Date:5/24/2013)...  An international roster of experts on malignant pleural ... Santa Monica, Calif. , to discuss their ... a rare form of cancer that results from exposure ... of the chest. Hosted by UCLA and ... Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural ...
(Date:5/24/2013)... NEW YORK , May 24, 2013 In ... Takeover Rules and Rule 14e-1 of the United States Exchange ... levels its original offer for Elan Corporation (NYSE: ELN). ... Acquisition Limited ("Royalty Pharma") made an offer for the entire ... Elan Corporation, plc ("Elan") (the "Original Offer").  ...
(Date:5/23/2013)... 24, 2013 3SBio Inc. (NASDAQ: ... leading China -based biotechnology company ... products, announced today that, at an extraordinary general ... voted in favor of the proposal to authorize ... of merger dated February 8, 2013, among Decade ...
Breaking Medicine Technology:International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 2International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 93SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3
... Presented at 2007 APA Meeting -, COLLEGEVILLE, ... four new studies examining safety and efficacy ... studied as a potential treatment for adults,with ... at the,2007 American Psychiatric Association annual meeting ...
... Childhood Condition, WASHINGTON, May 22, 2007 /PRNewswire-FirstCall/ ... pediatric patients,with gastroesophageal reflux disease (GERD) during ... Disease Week meeting held at the,Washington Convention ... support AstraZeneca's,commitment to research in the area ...
Cached Medicine Technology:New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 2New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 3New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 4New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 5New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 6New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 7New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 8New Studies Evaluating NexiumIn Pediatric GERD To Be Presented At,Annual Digestive Disease Week Meeting 2New Studies Evaluating NexiumIn Pediatric GERD To Be Presented At,Annual Digestive Disease Week Meeting 3New Studies Evaluating NexiumIn Pediatric GERD To Be Presented At,Annual Digestive Disease Week Meeting 4New Studies Evaluating NexiumIn Pediatric GERD To Be Presented At,Annual Digestive Disease Week Meeting 5
... order tips. Each box contains 10,000 tips ... in easy-to-open, re-sealable Bulk Packs of 200 ... with a tamper-proof strip which can easily ... Diamond Tips. Bulk Packs are closed using ...
Capillary section fits into a 0.3-mm well for accurate loading of sequencing gels - Ideal for use with CastAway System...
This extended 10 ul combats contamination by keeping your pipettor out of 1.5 ul and 2.0 ul tubes. Utilizes MicroPoint design and 2 ul reference mark....
... powerful motor with a lightweight, comfortable design. ... three positions for maximum comfort and convenience.mum ... button on the top of the filler ... wide-angle position is ideal for restricted spaces ...
Medicine Products: